Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells

Stem cell research has gained many attentions for their hope to cure myriad of disease ranging from genetically linked disorders to neurodegenerative diseases as well as injuries. Pluripotent stem cells signify the perpetual source of versatile cells, making them an excellent source for cell therapy...

Full description

Saved in:
Bibliographic Details
Main Author: Ferdaos, Nurfarhana
Format: Thesis
Language:English
English
Published: 2010
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/21278/1/FPSK%28m%29_2010_20_R.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-upm-ir.21278
record_format uketd_dc
spelling my-upm-ir.212782013-05-27T08:16:03Z Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells 2010-10 Ferdaos, Nurfarhana Stem cell research has gained many attentions for their hope to cure myriad of disease ranging from genetically linked disorders to neurodegenerative diseases as well as injuries. Pluripotent stem cells signify the perpetual source of versatile cells, making them an excellent source for cell therapy. Current discoveries have reported amniotic fluid as an alternative source for pluripotent stem cells, termed amniotic fluid as an alternative source for pluripotent stem cells, termed amniotic fluid-derived stem (AFS) cells. AFS cells have been shown to express embryonic and adult stem cell markers while hindering the ethical controversies, which has been the biggest issue involving the well-known pluripotent stem cells; the embryonic stem (ES) cells. In addition, AFS cells also do not form tumors upon transplantation. To date, only amniotic fluid of mid-term pregnancies has been reported to yield AFS cells. However, the collection of mid-term AF samples involves invasive procedure (amniocentesis) that may result in several complications including abortion. Therefore, in study, we aim to isolate and characterize AFS cells from human and rat full-term pregnancies. The heterogeneity of amniotic fluid (AF) cells was observed upon culturing the cells under the optimized conditions, prior to isolation of stem cells by immunoselection against c-Kit, a marker for stem cell factor. The isolation of cells positive for c-Kit using Magnetic-Activated Cell Sorting (MACS) technology has resulted in enrichment of the c-Kit positive cells. Characterization of the c-Kit positive cells has demonstrated the expression of Oct-4, a marker for pluripotent cells and the formation of embryoid bodies (EBs), suggesting the possibility of AFS cells being present during full-term pregnancy in mammals including human. Hence giving hopes that full-term AFS cells would be the future alternative source for stem cell therapy. Amniotic Fluid Stem Cell 2010-10 Thesis http://psasir.upm.edu.my/id/eprint/21278/ http://psasir.upm.edu.my/id/eprint/21278/1/FPSK%28m%29_2010_20_R.pdf application/pdf en public masters Universiti Putra Malaysia Amniotic Fluid Stem Cell Faculty Medicine and Health Sciences English
institution Universiti Putra Malaysia
collection PSAS Institutional Repository
language English
English
topic Amniotic Fluid
Stem Cell

spellingShingle Amniotic Fluid
Stem Cell

Ferdaos, Nurfarhana
Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells
description Stem cell research has gained many attentions for their hope to cure myriad of disease ranging from genetically linked disorders to neurodegenerative diseases as well as injuries. Pluripotent stem cells signify the perpetual source of versatile cells, making them an excellent source for cell therapy. Current discoveries have reported amniotic fluid as an alternative source for pluripotent stem cells, termed amniotic fluid as an alternative source for pluripotent stem cells, termed amniotic fluid-derived stem (AFS) cells. AFS cells have been shown to express embryonic and adult stem cell markers while hindering the ethical controversies, which has been the biggest issue involving the well-known pluripotent stem cells; the embryonic stem (ES) cells. In addition, AFS cells also do not form tumors upon transplantation. To date, only amniotic fluid of mid-term pregnancies has been reported to yield AFS cells. However, the collection of mid-term AF samples involves invasive procedure (amniocentesis) that may result in several complications including abortion. Therefore, in study, we aim to isolate and characterize AFS cells from human and rat full-term pregnancies. The heterogeneity of amniotic fluid (AF) cells was observed upon culturing the cells under the optimized conditions, prior to isolation of stem cells by immunoselection against c-Kit, a marker for stem cell factor. The isolation of cells positive for c-Kit using Magnetic-Activated Cell Sorting (MACS) technology has resulted in enrichment of the c-Kit positive cells. Characterization of the c-Kit positive cells has demonstrated the expression of Oct-4, a marker for pluripotent cells and the formation of embryoid bodies (EBs), suggesting the possibility of AFS cells being present during full-term pregnancy in mammals including human. Hence giving hopes that full-term AFS cells would be the future alternative source for stem cell therapy.
format Thesis
qualification_level Master's degree
author Ferdaos, Nurfarhana
author_facet Ferdaos, Nurfarhana
author_sort Ferdaos, Nurfarhana
title Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells
title_short Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells
title_full Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells
title_fullStr Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells
title_full_unstemmed Isolation and Characterization of Full-Term Ammoniotic Fluid-derived Stem Cells
title_sort isolation and characterization of full-term ammoniotic fluid-derived stem cells
granting_institution Universiti Putra Malaysia
granting_department Faculty Medicine and Health Sciences
publishDate 2010
url http://psasir.upm.edu.my/id/eprint/21278/1/FPSK%28m%29_2010_20_R.pdf
_version_ 1747811485712646144